ALLO

NASDAQ · Equity

Allogene Therapeutics Inc

US Healthcare Biotechnology

Latest week
29 May 2026
Close
2.170000
Fair value
2.508526
Expectation
Negative 41.31%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
2.17
12-Week Change
-9.58%
Trend Signal
Active
Expectation
Negative 41.31%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Below
Relative Strength
10.67
Market Dynamics
-0.68

Over the latest 12 completed weeks ending 2026-05-29, ALLO fell 9.58%, moving from 2.40 to 2.17. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 10.67 and has softened across the 12-week window. Market Dynamics is -0.68 on the latest week. Expectation is negative at 41.31%.